Skip to main content
103025 dlbcl banner session 2

Course Details

Released On

November 3, 2025

Expires On

October 30, 2026

Media Type

Internet

Specialties

Hematology & Oncology, Oncology

Completion Time

60 minutes

Topics

Oncology, Diffuse large B-cell lymphoma (DLBCL)

CME Info

Bridging the Gap Between Pathology and Oncology: BTK Inhibitors in DLBCL

This activity is jointly provided by Global Education Group and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC), in collaboration with American Society for Clinical Pathology (ASCP).

Acknowledgement

This program has been supported by an independent educational grant from AstraZeneca Pharmaceuticals.

Date of Release/Expiration

This activity was released on October 30, 2025, and is valid until October 30, 2026. Requests for credit must be made no later than October 30, 2026.

Credits Available

Physicians – maximum of 1.0 AMA PRA Category 1 Credit

Target Audience

The educational design of this activity addresses the needs of hematologists/oncologists, pathologists, NPs, PAs, and oncology nurses.

Program Overview

In the evolving treatment landscape of diffuse large B-cell lymphoma (DLBCL), clinicians need to stay up to date on how specific biomarkers influence diagnosis, prognosis, and therapeutic choice in DLBCL. Join two expert hematologists/oncologists to learn more about how biomarkers and cell-of-origin can be used to guide accurate diagnosis and prognosis as well as which patients would benefit from Bruton’s tyrosine kinase (BTK) inhibitors by assessing patient- and disease-specific factors for relapsed/refractory DLBCL.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Describe how biomarkers and cell-of-origin can be used to guide accurate diagnosis and prognosis and support therapeutic decision-making in DLBCL
  • Identify patients with DLBCL who are likely to benefit from BTK inhibitors by assessing patient- and disease-specific factors

Faculty

Joshua Brody, MD

Director, Lymphoma Immunotherapy Program
Icahn School of Medicine at Mount Sinai

Sarah C. Rutherford MD

Associate Professor of Clinical Medicine
Weill Cornell Medicine

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC). Global is accredited by the ACCME to provide continuing medical education for physicians. 

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Estimated Time to Complete

This activity should take approximately 60 minutes to complete.

Instructions to Recieve Credit

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media. 

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosure of Relevant Financial Relationships

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

The planners and managers at Global Education Group and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) have no relevant financial relationships to disclose.

Disclosures of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

PlatformQ Health Privacy Policy

By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.

Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.

In plain English, here is what we affirm:

  • You can change your registration profile at any time from our “Profile” page
  • To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at [email protected]
  • You can end your association with PlatformQ Health at any time
  • PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
  • EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting [email protected] with the subject line “Data Request”

You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/

Contact Information

Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].

Technical Support:
For any technical issues or issues with your CME Certificate, please contact Medlive at 877-394-1306 or at [email protected].